Navigating the area of terminal care and access to medications like this drug in New South Wales, the state, requires a careful understanding of the complex legal framework. Currently, copyright does not have a approved place on the Pharmaceutical Benefits Scheme (this program) and is therefore not regularly prescribed by healthcare professionals.